[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Albendazole Market based on Target Pathogen (Tapeworm, Hookworm, Pinworm, and Others), End-use (Ascaris Infection Treatment, Pinworm Infection Treatment, and Others) and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Veterinary Clinics) and Geography – Global Forecast up to 2026

March 2021 | 102 pages | ID: AA279F1824F9EN
Infoholic Research

US$ 4,000.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The albendazole market is significantly driven by one of the major factors: the rising prevalence of worm infestations majorly in the rural and underdeveloped areas. Along with that, the inadequacy of drinking water, dearth of cleanliness, and lack of permitted sanitation in few areas are the reasons responsible for the rising number of parasitic worms, which eventually increase the requirement of albendazole around the world. The Albendazole Market is projected to grow at the rate of 7.4% CAGR by 2026. Albendazole is a WHO-recommended prescription used for parasitic worm pervasive. It is an extensive range prescription, which is also known as albendazole. Albendazole is an orally taken medicine that is recognized as a significant and safe drug required for the health system. It is very useful in conditions such as hydatid disease, giardiasis, filariasis, trichuriasis, neurocysticercosis, pinworm disease, and ascariasis, among others. On the other hand, the negative effects of albendazole drugs are likely to hamper the albendazole market growth potential.

Albendazole Market based on Target Pathogen
  • Tapeworm
  • Hookworm
  • Pinworm
  • Others
Albendazole Market based on End-use
  • Ascaris Infection Treatment
  • Pinworm Infection Treatment
  • Others
Albendazole Market based on Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Veterinary Clinics
Albendazole Market based on Geography
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
Based on the target pathogen, the market is categorized into tapeworm, hookworm, pinworm, and others. The pinworm segment is expected to hold the major share in the market owing to the high possibility of infection through pinworms, specifically in children, which increases the demand for albendazole. The albendazole drug is considered effective medicine for killing pinworms.

Further, the market is segmented according to the end-use; again, the end-use segmentation is divided into Ascaris infection treatment, pinworm infection treatment, and others. The pinworm infection treatment is expected to dominate the albendazole market. This can be attributed to an increasing incidence of pinworm infections around the world, majorly in the underdeveloped areas where there is a lack of hygiene, inadequate drinking water, and lack of awareness about the importance of hygiene.

As per the market by distribution channel, the various distribution channels include hospital pharmacies, retail pharmacies, online pharmacies, and veterinary clinics. Online pharmacies are the significant distribution channel in the albendazole market due to the rising online purchases and the availability of various drugs in online pharmacies.

According to the market's regional penetration across the world, the North American region is holding the highest share in the albendazole market. This is ascribed to the increasing focus on research and development activities by key players in this region and the rising incidence of pinworm infections in the U.S.

Globally, the increasing prevalence of helminths infections which are caused by roundworm, hookworm, and other worms, is anticipated to boost the demand for anthelmintic drugs for infection treatment. This factor, in turn, will contribute to the growth of the global market. Moreover, the growing awareness regarding veterinary care raises the level of control and care of animals. This results in growth in the population of animals. Additionally, the improvements in veterinary education in the past few decades have placed greater importance on animal welfare, owing to which the demand for albendazole has increased in animal care.

This report includes the key vendors operating in the market - Sequent Scientifi, Lasa Laboratory Pvt Ltd, CHANGZHOU YABANG, GlaxoSmithKline, MANAV DRUGS, Ashish life Science Pvt. Ltd., Huazhong Pharmaceutical, K.A.Malle Pharmaceuticals, HUBEI KEYI, Fredun Pharmaceuticals Ltd, Salius Pharma, Leo Bio-Care Pvt. and Hubei Zhongjia-chem pharmaceutical.

The albendazole drug has been considered as the safe and crucial medicine around the world, which is required for the health system. Moreover, the governments of few developing countries are taking initiatives to tackle the increasing incidence of infectious diseases among rural areas.
  • The albendazole market report covers the trends such as the complete range of consumer trends and manufacturer trends
  • The report further focuses on the major market opportunities and challenges in the forecasted timeframe.
  • The report provides the Competitive outlook with analysis on competition pattern, portfolio comparisons, development trends, and strategic management
  • The report also entails the overall company profiles of the key players in the albendazole market
1. EXECUTIVE SUMMARY

2. INDUSTRY OUTLOOK

2.1. Industry Overview
2.2. Industry Trends

3. MARKET SNAPSHOT

3.1. Market Definition
3.2. Market Outlook
  3.2.1. Porter Five Forces
3.3. Related Markets

4. MARKET CHARACTERISTICS

4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
4.4. DRO - Impact Analysis

5. TARGET PATHOGEN: MARKET SIZE & ANALYSIS

5.1. Overview
5.2. Tapeworm
5.3. Hookworm
5.4. Pinworm
5.5. Others

6. END-USE: MARKET SIZE & ANALYSIS

6.1. Overview
6.2. Ascaris Infection Treatment
6.3. Pinworm Infection Treatment
6.4. Others

7. DISTRIBUTION CHANNEL: MARKET SIZE & ANALYSIS

7.1. Overview
7.2. Hospital Pharmacies
7.3. Retail Pharmacies
7.4. Online Pharmacies
7.5. Veterinary Clinics

8. GEOGRAPHY: MARKET SIZE & ANALYSIS

8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World

9. COMPETITIVE LANDSCAPE

9.1. Competitor Comparison Analysis
9.2. Market Developments
  9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
  9.2.2. Product Launches and execution

10. VENDOR PROFILES

10.1. Sequent Scientifi
  10.1.1. Overview
  10.1.2. Financial Overview
  10.1.3. Product Offerings
  10.1.4. Developments
  10.1.5. Business Strategy
10.2. Lasa Laboratory Pvt Ltd
  10.2.1. Overview
  10.2.2. Financial Overview
  10.2.3. Product Offerings
  10.2.4. Developments
  10.2.5. Business Strategy
10.3. CHANGZHOU YABANG
  10.3.1. Overview
  10.3.2. Financial Overview
  10.3.3. Product Offerings
  10.3.4. Developments
  10.3.5. Business Strategy
10.4. GlaxoSmithKline
  10.4.1. Overview
  10.4.2. Financial Overview
  10.4.3. Product Offerings
  10.4.4. Developments
  10.4.5. Business Strategy
10.5. MANAV DRUGS
  10.5.1. Overview
  10.5.2. Financial Overview
  10.5.3. Product Offerings
  10.5.4. Developments
  10.5.5. Business Strategy
10.6. Ashish life Science Pvt. Ltd.
  10.6.1. Overview
  10.6.2. Financial Overview
  10.6.3. Product Offerings
  10.6.4. Developments
  10.6.5. Business Strategy
10.7. Huazhong Pharmaceutical
  10.7.1. Overview
  10.7.2. Financial Overview
  10.7.3. Product Offerings
  10.7.4. Developments
  10.7.5. Business Strategy
10.8. K.A.Malle Pharmaceuticals
  10.8.1. Overview
  10.8.2. Financial Overview
  10.8.3. Product Offerings
  10.8.4. Developments
  10.8.5. Business Strategy
10.9. HUBEI KEYI
  10.9.1. Overview
  10.9.2. Financial Overview
  10.9.3. Product Offerings
  10.9.4. Developments
  10.9.5. Business Strategy
10.10. Fredun Pharmaceuticals Ltd
  10.10.1. Overview
  10.10.2. Financial Overview
  10.10.3. Product Offerings
  10.10.4. Developments
  10.10.5. Business Strategy

11. COMPANIES TO WATCH

11.1. Salius Pharma
  11.1.1. Overview
  11.1.2. Products & Services
  11.1.3. Business Strategy
11.2. Leo Bio-Care Pvt.
  11.2.1. Overview
  11.2.2. Products & Services
  11.2.3. Business Strategy
11.3. Hubei Zhongjia-chem Pharmaceutical
  11.3.1. Overview
  11.3.2. Products & Services
  11.3.3. Business Strategy

12. ANALYST OPINION

13. ANNEXURE

13.1. Report Scope
13.2. Market Definitions
13.3. Research Methodology
  13.3.1. Data Collation and In-house Estimation
  13.3.2. Market Triangulation
  13.3.3. Forecasting
13.4. Report Assumptions
13.5. Declarations
13.6. Stakeholders
13.7. Abbreviations

TABLES

TABLE 1. GLOBAL ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 2. GLOBAL ALBENDAZOLE MARKET VALUE FOR TAPEWORM, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 3. GLOBAL ALBENDAZOLE MARKET VALUE FOR HOOKWORM, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 4. GLOBAL ALBENDAZOLE MARKET VALUE FOR PINWORM, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 5. GLOBAL ALBENDAZOLE MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 6. GLOBAL ALBENDAZOLE MARKET VALUE, BY END-USE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 7. GLOBAL ALBENDAZOLE MARKET VALUE FOR ASCARIS INFECTION TREATMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 8. GLOBAL ALBENDAZOLE MARKET VALUE FOR PINWORM INFECTION TREATMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 9. GLOBAL ALBENDAZOLE MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 10. GLOBAL ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 11. GLOBAL ALBENDAZOLE MARKET VALUE FOR HOSPITAL PHARMACIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 12. GLOBAL ALBENDAZOLE MARKET VALUE FOR RETAIL PHARMACIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 13. GLOBAL ALBENDAZOLE MARKET VALUE FOR ONLINE PHARMACIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 14. GLOBAL ALBENDAZOLE MARKET VALUE FOR VETERINARY CLINICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 15. NORTH AMERICA ALBENDAZOLE MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 16. NORTH AMERICA ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 17. NORTH AMERICA ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 18. NORTH AMERICA ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 19. U.S ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 20. U.S ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 21. U.S ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 22. CANADA ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 23. CANADA ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 24. CANADA ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 25. EUROPE ALBENDAZOLE MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 26. EUROPE ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 27. EUROPE ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 28. EUROPE ALBENDAZOLE MARKET VALUE, DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 29. GERMANY ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 30. GERMANY ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 31. GERMANY ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 32. U.K ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 33. U.K ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 34. U.K ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 35. FRANCE ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 36. FRANCE ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 37. FRANCE ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 38. ITALY ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 39. ITALY ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 40. ITALY ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 41. SPAIN ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 42. SPAIN ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 43. SPAIN ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 44. ROE ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 45. ROE ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 46. ROE ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 47. ASIA PACIFIC ALBENDAZOLE MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 48. ASIA PACIFIC ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 49. ASIA PACIFIC ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 50. ASIA PACIFIC ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 51. CHINA ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 52. CHINA ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 53. CHINA ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 54. INDIA ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 55. INDIA ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 56. INDIA ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 57. JAPAN ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 58. JAPAN ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 59. JAPAN ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 60. REST OF APAC ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 61. REST OF APAC ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 62. REST OF APAC ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 63. REST OF WORLD ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
TABLE 64. REST OF WORLD ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
TABLE 65. REST OF WORLD ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
TABLE 66. SEQUENT SCIENTIFI: FINANCIALS
TABLE 67. SEQUENT SCIENTIFI: PRODUCT AND SERVICES
TABLE 68. SEQUENT SCIENTIFI: RECENT DEVELOPMENTS
TABLE 69. SEQUENT SCIENTIFI: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 70. LASA LABORATORY PVT LTD: FINANCIALS
TABLE 71. LASA LABORATORY PVT LTD: PRODUCT AND SERVICES
TABLE 72. LASA LABORATORY PVT LTD: RECENT DEVELOPMENTS
TABLE 73. LASA LABORATORY PVT LTD: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 74. CHANGZHOU YABANG: FINANCIALS
TABLE 75. CHANGZHOU YABANG: PRODUCT AND SERVICES
TABLE 76. CHANGZHOU YABANG: RECENT DEVELOPMENTS
TABLE 77. CHANGZHOU YABANG: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 78. GLAXOSMITHKLINE: FINANCIALS
TABLE 79. GLAXOSMITHKLINE: PRODUCT AND SERVICES
TABLE 80. GLAXOSMITHKLINE: RECENT DEVELOPMENTS
TABLE 81. GLAXOSMITHKLINE: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 82. MANAV DRUGS: FINANCIALS
TABLE 83. MANAV DRUGS: PRODUCT AND SERVICES
TABLE 84. MANAV DRUGS: RECENT DEVELOPMENTS
TABLE 85. MANAV DRUGS: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 86. ASHISH LIFE SCIENCE PVT. LTD: FINANCIALS
TABLE 87. ASHISH LIFE SCIENCE PVT. LTD: PRODUCT AND SERVICES
TABLE 88. ASHISH LIFE SCIENCE PVT. LTD: RECENT DEVELOPMENTS
TABLE 89. ASHISH LIFE SCIENCE PVT. LTD: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 90. HUAZHONG PHARMACEUTICAL: FINANCIALS
TABLE 91. HUAZHONG PHARMACEUTICAL: PRODUCT AND SERVICES
TABLE 92. HUAZHONG PHARMACEUTICAL: RECENT DEVELOPMENTS
TABLE 93. HUAZHONG PHARMACEUTICAL: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 94. K.A.MALLE PHARMACEUTICALS: FINANCIALS
TABLE 95. K.A.MALLE PHARMACEUTICALS: PRODUCT AND SERVICES
TABLE 96. K.A.MALLE PHARMACEUTICALS: RECENT DEVELOPMENTS
TABLE 97. K.A.MALLE PHARMACEUTICALS: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 98. HUBEI KEYI: FINANCIALS
TABLE 99. HUBEI KEYI: PRODUCT AND SERVICES
TABLE 100. HUBEI KEYI: RECENT DEVELOPMENTS
TABLE 101. HUBEI KEYI: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 102. FREDUN PHARMACEUTICALS LTD: FINANCIALS
TABLE 103. FREDUN PHARMACEUTICALS LTD: PRODUCT AND SERVICES
TABLE 104. FREDUN PHARMACEUTICALS LTD: RECENT DEVELOPMENTS
TABLE 105. FREDUN PHARMACEUTICALS LTD: APPLICATION/SERVICE PROVIDER PORTFOLIO
TABLE 106. SALIUS PHARMA: PRODUCT AND SERVICES
TABLE 107. LEO BIO-CARE PVT: PRODUCT AND SERVICES
TABLE 108. HUBEI ZHONGJIA-CHEM PHARMACEUTICAL: PRODUCT AND SERVICES

CHARTS

CHART. 1. GLOBAL ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 2. GLOBAL ALBENDAZOLE MARKET VALUE FOR TAPEWORM, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 3. GLOBAL ALBENDAZOLE MARKET VALUE FOR HOOKWORM, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 4. GLOBAL ALBENDAZOLE MARKET VALUE FOR PINWORM, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 5. GLOBAL ALBENDAZOLE MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 6. GLOBAL ALBENDAZOLE MARKET VALUE, BY END-USE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 7. GLOBAL ALBENDAZOLE MARKET VALUE FOR ASCARIS INFECTION TREATMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 8. GLOBAL ALBENDAZOLE MARKET VALUE FOR PINWORM INFECTION TREATMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 9. GLOBAL ALBENDAZOLE MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 10. GLOBAL ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 11. GLOBAL ALBENDAZOLE MARKET VALUE FOR HOSPITAL PHARMACIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 12. GLOBAL ALBENDAZOLE MARKET VALUE FOR RETAIL PHARMACIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 13. GLOBAL ALBENDAZOLE MARKET VALUE FOR ONLINE PHARMACIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 14. GLOBAL ALBENDAZOLE MARKET VALUE FOR VETERINARY CLINICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 15. NORTH AMERICA ALBENDAZOLE MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 16. NORTH AMERICA ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 17. NORTH AMERICA ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 18. NORTH AMERICA ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 19. U.S ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 20. U.S ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 21. U.S ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 22. CANADA ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 23. CANADA ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 24. CANADA ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 25. EUROPE ALBENDAZOLE MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 26. EUROPE ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 27. EUROPE ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 28. EUROPE ALBENDAZOLE MARKET VALUE, DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 29. GERMANY ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 30. GERMANY ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 31. GERMANY ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 32. U.K ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 33. U.K ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 34. U.K ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 35. FRANCE ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 36. FRANCE ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 37. FRANCE ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 38. ITALY ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 39. ITALY ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 40. ITALY ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 41. SPAIN ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 42. SPAIN ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 43. SPAIN ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 44. ROE ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 45. ROE ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 46. ROE ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 47. ASIA PACIFIC ALBENDAZOLE MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 48. ASIA PACIFIC ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 49. ASIA PACIFIC ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 50. ASIA PACIFIC ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 51. CHINA ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 52. CHINA ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 53. CHINA ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 54. INDIA ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 55. INDIA ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 56. INDIA ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 57. JAPAN ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 58. JAPAN ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 59. JAPAN ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 60. REST OF APAC ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 61. REST OF APAC ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 62. REST OF APAC ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)
CHART. 63. REST OF WORLD ALBENDAZOLE MARKET VALUE, BY TARGET PATHOGEN, 2020-2026 (USD BILLION)
CHART. 64. REST OF WORLD ALBENDAZOLE MARKET VALUE, BY END-USE, 2020-2026 (USD BILLION)
CHART. 65. REST OF WORLD ALBENDAZOLE MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2026 (USD BILLION)


More Publications